NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Prothea Technologies

Prothea Technologies

Private
EdinburghHealthcare & Life Scienceshttps://prothea.tech/

Last Round

Series A

Apr 9, 2024

Total Funding Raised

$13M

Company Overview

Prothea Technologies is a medical technology company that is developing an integrated diagnostic and treatment platform for lung cancer to enable biopsy and treatment in a single hospital visit.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Medical AI

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

medical devicelung cancer diagnosismedical imagingfibreoptic microendoscopemedtechAI-powered diagnosticslaser ablationbronchoscopyclinical decision supportbiopsydigital pathologyinterventional pulmonologyimage processingsurgical robotics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Prothea Technologies Comparables

Compare Prothea Technologies with similar companies based on industry and business-model similarity.

Prothea Technologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
LEADOPTIK
82%
Prana Surgical
78%
Body Vision Medical
78%

Prothea Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AApr 9, 2024

Key People

Founding team and executive leadership

Kev Dhaliwal

Co founder , Chief Scientific Officer Chief Medical Officer

Founding Team

Jim Stone

Chief Technology Officer

Executive Team

Prothea Technologies Investors

Notable investors and investment history

Prothea Technologies investors
InvestorRounds
KorysSeries A
Old College CapitalSeries A
NRW.BankSeries A
Earlybird Venture CapitalSeries A
Mérieux Equity PartnersSeries A

Prothea Technologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Prothea Technologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Prothea Technologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersEdinburgh
Employee Range22
Year Founded2021
Last FundingApr 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.